Corporate Information

Krebs Biochemicals & Industries Ltd Industry : (Pharmaceuticals)

BSE Code : 524518

NSE Symbol : KREBSBIO

P/E(TTM) : -

ISIN Demat : INE268B01013

Div & Yield% : -

EPS(TTM) : -

Book Value(₹) : -60.36

Market Cap(₹Cr) : 219.92

Face Value(₹) : 10.00

Particulars Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
INCOME :          
Sales Turnover 50.42 52.13 59.70 53.70 33.41
Excise Duty - - - - -
Net Sales 50.42 52.13 59.70 53.70 33.41
Other Income 0.45 0.62 1.16 0.62 0.37
Stock Adjustments -1.07 -5.87 5.54 -0.32 3.32
Total Income 49.80 46.88 66.40 54.00 37.10
EXPENDITURE :          
Raw Materials 5.52 19.81 46.18 25.62 19.18
Power and Fuel Cost 22.01 14.80 22.23 15.91 10.28
Other Manufacturing Expenses 9.75 7.17 9.64 10.48 6.95
Selling and Administration Expenses 4.50 4.57 6.11 3.39 4.01
Miscellaneous Expenses 0.11 0.17 0.11 0.24 0.31
Employee Benefit Expenses 16.17 15.54 14.96 15.30 14.56
Less: Preoperative Expenditure - - - - -
Total Expenses - - - - -
Operating Profit -8.27 -15.16 -32.84 -16.95 -18.19
Interest 4.69 2.97 5.39 6.28 6.00
Gross Profit -12.96 -18.13 -38.23 -23.23 -24.19
Depreciation 6.77 6.56 6.30 5.12 4.68
Profit Before Tax -19.73 -24.69 -44.53 -28.35 -28.87
Current Tax - - - - -
Fringe Benefit tax - - - - -
Deferred Tax - - - - -
Reported Net Profit -19.73 -24.69 -44.53 -28.36 -28.87
Extraordinary Items - - - - 0.01
Adjusted Net Profit -19.73 -24.69 -44.53 -28.36 -28.88
Adjustment below Net Profit -0.03 0.32 -0.35 0.17 6.38
Profit/Loss Balance carried down -250.49 -226.12 -181.24 -153.06 -111.86
Statutory Appropriations - - - - -
Appropriations - - - - -
P & L Balance carried down -270.24 -250.49 -226.12 -181.24 -134.35
Dividend - - - - -
Preference Dividend - - - - -
Equity Dividend (%) - - - - -
Dividend Per Share(Rs) - - - - -
Earnings Per Share-Unit Curr -9.15 -11.45 -20.65 -14.45 -16.04
Earnings Per Share(Adj)-Unit Curr -9.15 -11.45 -20.65 -14.45 -16.04
Book Value -55.29 -46.13 -34.83 -23.91 -13.89
Book Value(Adj)-Unit Curr -55.29 -46.13 -34.83 -23.91 -13.89